Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opus Genetics (IRD) Accumulated Expenses (2021 - 2024)

Opus Genetics (IRD) has disclosed Accumulated Expenses for 3 consecutive years, with $3.4 million as the latest value for Q2 2023.

  • On a quarterly basis, Accumulated Expenses rose 941.82% to $3.4 million in Q2 2023 year-over-year; TTM through Jun 2023 was $3.4 million, a 941.82% increase, with the full-year FY2022 number at $782000.0, down 54.88% from a year prior.
  • Accumulated Expenses was $3.4 million for Q2 2023 at Opus Genetics, up from $233000.0 in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $3.4 million in Q2 2023 to a low of $193000.0 in Q1 2022.
  • A 3-year average of $1.1 million and a median of $895000.0 in 2021 define the central range for Accumulated Expenses.
  • Peak YoY movement for Accumulated Expenses: crashed 78.44% in 2022, then soared 941.82% in 2023.
  • Opus Genetics' Accumulated Expenses stood at $1.7 million in 2021, then plummeted by 54.88% to $782000.0 in 2022, then soared by 339.64% to $3.4 million in 2023.
  • Per Business Quant, the three most recent readings for IRD's Accumulated Expenses are $3.4 million (Q2 2023), $233000.0 (Q1 2023), and $782000.0 (Q4 2022).